PepsiCo (PEP) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
23 Dec, 2025Executive summary
Net revenue for Q2 2025 was $22.7B, up 1% year-over-year, with organic revenue up 2.1%; operating profit fell 56% due to $1.86B–$1.9B in impairment charges, higher costs, and restructuring expenses.
Net income attributable to shareholders dropped 59% to $1.26B for the quarter, with diluted EPS at $0.92, down from $2.23 a year ago; core EPS was $2.12, down 5% in constant currency.
Major impairment charges were related to the Rockstar and Be & Cheery brands, impacting PBNA, EMEA, and Asia Pacific Foods segments.
Acquisitions of Siete and poppi were completed for $1.2B and $1.95B, expanding the PFNA and PBNA segments.
Focus on multi-year productivity initiatives, leveraging technology, AI, and data to optimize cost structure and drive growth, especially through North America business integration.
Financial highlights
Q2 2025 net revenue: $22.7B (+1% year-over-year); YTD net revenue: $40.6B (flat year-over-year).
Operating profit: $1.8B for the quarter (-56% year-over-year); $4.4B for 24 weeks (-35%).
Net income attributable to shareholders: $1.26B for the quarter (-59%); $3.1B for 24 weeks (-40%).
Gross margin for Q2 2025: 54.7%; operating margin: 7.9%.
Free cash flow for 24 weeks was negative $342M, down from negative $259M a year ago.
Outlook and guidance
2025 guidance affirms low-single-digit organic revenue growth and core constant currency EPS roughly flat with prior year.
Management expects to return approximately $8.6B to shareholders in 2025, with $7.6B in dividends and $1.0B in share repurchases.
Ongoing productivity initiatives and cost management are expected to continue, with the 2019 Productivity Plan extended through 2030.
Foreign exchange headwind for 2025 now expected at 1.5 percentage points, improved from previous 3 points.
High confidence in delivering back-half productivity and mitigating tariff impacts.
Latest events from PepsiCo
- $94B revenue, health-driven innovation, and global expansion drive growth and margin targets.PEP
Consumer Analyst Group of New York Conference (CAGNY) 202618 Feb 2026 - Q1 2025: revenue, income, and EPS down; guidance cut; dividend up 5%; acquisitions ongoing.PEP
Q1 20253 Feb 2026 - Affordability, innovation, and strong Q4 results drive growth and higher dividends in 2026.PEP
Q4 20253 Feb 2026 - Q2 2024 delivered strong EPS and margin gains, but Quaker recall and guidance cut weighed.PEP
Q2 20243 Feb 2026 - Q3 profit fell on higher costs and recall, but core EPS and shareholder returns remain strong.PEP
Q3 202419 Jan 2026 - 2024 saw margin and EPS growth; 2025 outlook is cautious but targets continued gains and higher dividend.PEP
Q4 20249 Jan 2026 - Portfolio innovation, digitalization, and global expansion drive strong growth and future targets.PEP
Consumer Analyst Group of New York Conference (CAGNY ) 20258 Jan 2026 - 2026 targets 2–4% organic revenue and 4–6% core EPS growth, driven by innovation and cost savings.PEP
Status Update12 Dec 2025 - Annual meeting to vote on directors, auditor, executive pay, and four shareholder proposals.PEP
Proxy Filing1 Dec 2025